Biological variability dominates and influences analytical variance in HPLC-ECD studies of the human plasma metabolome

被引:23
作者
Shurubor, Yevgeniya [1 ,2 ]
Matson, Wayne [3 ,4 ]
Willett, Walter [3 ,4 ,5 ]
Hankinson, Susan [3 ,4 ,6 ]
Kristal, Bruce [1 ,2 ,7 ]
机构
[1] Brigham & Womens Hosp, Dept Neurosurg, 221 Longwood Ave,LM322B, Boston, MA 02115 USA
[2] Burke Med Res Inst, White Plains, NY 10605 USA
[3] ESA Inc, Chelmsford, MA 01824 USA
[4] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA
[5] Harvard Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA
[6] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[7] Cornell Univ, Med Coll, Dept Neurosci, New York, NY 10021 USA
来源
BMC CLINICAL PATHOLOGY | 2007年 / 7卷
关键词
D O I
10.1186/1472-6890-7-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Biomarker-based assessments of biological samples are widespread in clinical, preclinical, and epidemiological investigations. We previously developed serum metabolomic profiles assessed by HPLC-separations coupled with coulometric array detection that can accurately identify ad libitum fed and caloric-restricted rats. These profiles are being adapted for human epidemiology studies, given the importance of energy balance in human disease. Methods: Human plasma samples were biochemically analyzed using HPLC separations coupled with coulometric electrode array detection. Results: We identified these markers/metabolites in human plasma, and then used them to determine which human samples represent blinded duplicates with 100% accuracy (N = 30 of 30). At least 47 of 61 metabolites tested were sufficiently stable for use even after 48 hours of exposure to shipping conditions. Stability of some metabolites differed between individuals (N = 10 at 0, 24, and 48 hours), suggesting the influence of some biological factors on parameters normally considered as analytical. Conclusion: Overall analytical precision (mean median CV, similar to 9%) and total between-person variation (median CV, similar to 50-70%) appear well suited to enable use of metabolomics markers in human clinical trials and epidemiological studies, including studies of the effect of caloric intake and balance on long-term cancer risk.
引用
收藏
页数:14
相关论文
共 67 条
  • [21] KRISTAL B, 2005, METABOLIC PROFILING
  • [22] Kristal Bruce S, 2002, Methods Mol Biol, V186, P185
  • [23] Simultaneous analysis of the majority of low-molecular-weight, redox-active compounds from mitochondria
    Kristal, BS
    Vigneau-Callahan, KE
    Matson, WR
    [J]. ANALYTICAL BIOCHEMISTRY, 1998, 263 (01) : 18 - 25
  • [24] Identification of disease- and nutrient-related metabolic fingerprints in osteoarthritic guinea pigs
    Lamers, RJAN
    DeGroot, J
    Spies-Faber, EJ
    Jellema, RH
    Kraus, VB
    Verzijl, N
    TeKoppele, JM
    Spijksma, GK
    Vogels, JTWE
    van der Greef, J
    van Nesselrooij, JHJ
    [J]. JOURNAL OF NUTRITION, 2003, 133 (06) : 1776 - 1780
  • [25] OPEN about obesity: recovery biomarkers, dietary reporting errors and BMI
    Lissner, L.
    Troiano, R. P.
    Midthune, D.
    Heitmann, B. L.
    Kipnis, V.
    Subar, A. F.
    Potischman, N.
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 (06) : 956 - 961
  • [26] Markers of the validity of reported energy intake
    Livingstone, MBE
    Black, AE
    [J]. JOURNAL OF NUTRITION, 2003, 133 (03) : 895S - 920S
  • [27] Methodologic and statistical considerations regarding use of biomarkers of nutritional exposure in epidemiology
    Marshall, JR
    [J]. JOURNAL OF NUTRITION, 2003, 133 (03) : 881S - 887S
  • [28] MATSON WR, 1984, CLIN CHEM, V30, P1477
  • [29] EC ARRAY SENSOR CONCEPTS AND DATA
    MATSON, WR
    GAMACHE, PG
    BEAL, MF
    BIRD, ED
    [J]. LIFE SCIENCES, 1987, 41 (07) : 905 - 908
  • [30] Matson WR, 1990, BASIC CLIN THERAPEUT, VII, P513